Idxg stock.

Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-3.59 Market Cap $3.59 M Shares Outstanding 4.32 M Public Float 3.09 M Yield IDXG is not currently paying a regular dividend. Latest Dividend N/A...Stock analysis for Interpace Biosciences Inc (IDXG:OTC US) including stock price, stock chart, company news, key statistics, fundamentals and company profile.finance.yahoo.com - July 10 at 8:15 PM. Interpace Expects to Stop Offering PancraGEN® Test Due to CMS Decision to End Reimbursement as of July 17, 2023. finance.yahoo.com - June 5 at 4:41 PM. Interpace Biosciences, Inc.: Interpace Biosciences Announces Record First Quarter 2023 Financial and Business Results.IDXG Overview Stock Screener Earnings Calendar Sectors | IDXG U.S.: OTC Interpace Biosciences Inc. Watch list NEW Set a price target alert Closed Last Updated: Nov 1, 2023 3:48 p.m. EDT... NEW YORK, Nov. 29, 2017 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key

IDXG is the ticker symbol for Interpace Biosciences, Inc., a company that provides molecular diagnostic tests for cancer and other diseases. The stock price, news, quote and history …

IDXG Stock Return DVA Stock Return ... We favor stocks that offer meaningfully greater expected return in the next 3 years; These returns are calculated based on our revenue forecast and Price to Sales Ratio (P/S) scenarios considered; Similar Price To Sales Ratio (P/S) scenarios are considered for both stocks and each scenario is weighted ...A solid price increase over a period of 12 weeks reflects investors' continued willingness to pay more for the potential upside in a stock. IDXG is quite a good fit in this regard, gaining 42.5% ...

(RTTNews) - Shares of Interpace Biosciences Inc. (IDXG) are gaining nearly 15% on Thursday morning after the company announced a contract for thyroid testing with Blue Cross Blue Shield of Florida ...Discover historical prices for IDXG stock on Yahoo Finance. View daily, weekly or monthly formats back to when Interpace Diagnostics Group, Inc. stock was …Interpace Biosciences, Inc. (IDXG) Stock Price, Quote & News - Stock Analysis Interpace Biosciences, Inc.) No 1Y chart data available IDXG In 2022, IDXG's …60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share.Jun 5, 2023 · 06/05/2023 - 04:05 PM . PARSIPPANY, NJ, June 05, 2023 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced that the Centers for Medicare & Medicaid Services (CMS) issued the final Local Coverage Determination (LCD) of Genetic Testing for Oncology (L39365) which establishes non-coverage for the Company’s widely used PancraGEN ...

Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...

Interpace Biosciences Inc. (IDXG) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.

Part of Company’s Site Consolidation and Cost Savings Measures . Parsippany, NJ, March 17, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (OTC: IDXG) announced today that it has entered into a definitive agreement to sell its New Haven CT CLIA certified, CAP accredited laboratory to DiamiR Biosciences, Corp. …See historical performance and comparison. View Valuation. Research Interpace Biosciences' (OTCPK:IDXG) stock price, latest news & stock analysis. Find …The estimated Net Worth of Thomas W. Burnell is at least $437 millier dollars as of 21 May 2021. Dr Burnell owns over 10,855 units of Interpace Biosciences Inc stock worth over $12,158 and over the last 3 years he sold IDXG stock worth over $0. In addition, he makes $425,004 as Pres et CEO & Director at Interpace Biosciences Inc.--- - Interpace Biosciences, Inc. (NASDAQ:IDXG) major shareholder Peter Kamin bought 83,250 shares of the companys stock in a transaction that occurred on Monday, March 1st. The stock was bought at an average price of $3.12 per share, with a total value of $259,740.00.IDEXX Laboratories, Inc. Common Stock (IDXX) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.The Price to Sales ratio or P/S is calculated as price divided by sales. After the P/E ratio, it's one of the most common valuation metrics. If the P/S ratio is 1, that means you're paying $1 for ...

home / stock / idxg / idxg news. RSS . IDXG IDXG Quote IDXG Short IDXG News IDXG Articles IDXG Message Board. November, 08 2023 03:29 PM | GlobeNewswire | More on IDXG.After Hours trades will be posted from 4:15 p.m. ET to 3:30 p.m. ET of the following day. Data provided by Nasdaq Data Link, a premier source for financial, economic and alternative datasets. Data ...Find the latest Interpace Biosciences, Inc. (IDXG) stock quote, history, news and other vital information to help you with your stock trading and investing.Interpace Biosciences Inc. (IDXG) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.Interpace Biosciences Inc. Annual stock financials by MarketWatch. View the latest IDXG financial statements, income statements and financial ratios. Third quarter Net Revenue was. Find the latest Interpace Diagnostics Group, Inc. (IDXG) stock quote, history, news and other vital information to help you with your stock trading …

Dr D IDXG stock SEC Form 4 insiders trading. Dr has made over 1 trades of the Interpace Biosciences Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he bought 10,855 units of IDXG stock worth $94,221 on 21 May 2021.10,855 units of IDXG stock worth $94,221 on 21 May 2021.© Valve Corporation สงวนสิทธิ์ทุกประการ เครื่องหมายการค้าทั้งหมดเป็น ...

PARSIPPANY, NJ, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced financial results for the second quarter ended June 30, 2022 and provided a business and financial update.Interpace Biosciences Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time IDXG stock price. Establishing ownership of stock depends on how the stock was purchased, according to the Securities and Exchange Commission. A brokerage firm may have purchased the stock or it may have been bought directly from the company.© Valve Corporation. Todos los derechos reservados. Todas las marcas registradas pertenecen a sus respectivos dueños en EE. UU. y otros países.١٨ جمادى الأولى ١٤٤١ هـ ... Parsippany, NJ, January 13, 2020 -- Interpace Biosciences, Inc. (Nasdaq: IDXG) ... The new Series B Preferred Stock investment will be convertible ...Interpace Biosciences Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time IDXG stock price. Interpace Diagnostics Announces European Patent Approval For Underlying Technology of its ThyraMIR® microRNA Classifier PR Newswire PARSIPPANY, N.J., April 3,Interpace Biosciences Inc. (IDXG) Message Board - Company Name: Interpace Biosciences Inc., Stock Symbol: IDXG, Industry: Medical - Healthcare - Total Posts: 2811 - Last Post: 07/11/2023 09:52:18 AM - company/specific stock board

ISIN. US46062X3035. Interpace Biosciences, Inc. engages in the development and sale of diagnostic clinical and pharma services. It offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion molecular test, ThyGenX, an expanded oncogenic mutation panel that helps identify malignant thyroid nodules, ThyraMIR, which assesses thyroid ...

- Depositary Shares representing 1/1000th Series B Preferred Stock, AGNCB. 32 ... IDXG. 1926. Intersect ENT Inc, XENT. 1927. Intersections Inc. INTX. 1928.

James Early IDXG stock SEC Form 4 insiders trading. James has made over 1 trades of the Interpace Biosciences Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently James exercised 5,000 units of IDXG stock worth $6,050 on 29 July 2020.5,000 units of IDXG stock worth $6,050 on 29 July 2020.60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. Interpace Biosciences Inc’s trailing 12-month revenue is $37.4 million with a -40.8% profit margin. Year-over-year quarterly sales growth most recently was -28.1%. There are not analysts providing consensus earnings estimates for the current fiscal year. Interpace Biosciences Inc does not currently pay a dividend.Get the latest Interpace Biosciences, Inc. (IDXG) stock news and headlines to help you in your trading and investing decisions.Interpace Biosciences Inc (OTC:IDXG) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds (or held) more ... Aug 31, 2022 · Interpace Biosciences on Wednesday said it had closed the sale of its pharma services business to Flagship Biosciences.IDXG CEO Thomas Burnell said with the completion of the deal, the company's ... Interpace Announces Coverage of ThyraMIR® with UnitedHealthcare PR Newswire PARSIPPANY, N.J., April 18, 2017 PARSIPPANY, N.J. , April 18, 2017 /PRNewswire/ --1.31. Shareholder percentage totals can add to more than 100% because some holders are included in the free float. The latest Interpace Biosciences stock prices, stock quotes, news, and IDXG ... Pennsylvania and Connecticut Labs Both Receive Accreditation. PARSIPPANY, NJ, April 25, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that it has received the College of American Pathologists (“CAP”) accreditation for its Pittsburgh, Pennsylvania and New Haven, …

Interpace Diagnostics Announces New Partnership with Israeli Specialty Services Provider PR Newswire PARSIPPANY, N.J., Jan. 20, 2017 PARSIPPANY, N.J. , Jan. 20,Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Interpace Biosciences Inc have a median target of 11.00, with a high estimate of 11.00 and a low estimate of 11.00. The median estimate represents a +909.17% increase from the last price of 1.09. Chart unavailable. LONG BEACH, Calif., November 13, 2023--The Beauty Health Company announced financial results for the third quarter ended September 30, 2023. Find the latest The Beauty Health Company (SKIN) stock ...Interpace Biosciences, Inc. (IDXG.) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Interpace Biosciences, Inc. | OTC …Instagram:https://instagram. how to make money from currency exchangebest broker for forex in usall flooring holdingsbest tax free bond funds Gerald Belle, Director at Interpace Diagnostics Group (IDXG), has a 16.67% success rate when buying and selling stocks. ... Popular. Stock Screener Top Online Growth Stocks Trending Stocks Penny Stock Screener. Dividend Investing. Dividend Calculator Dividend Yield Calculator Dividend Stocks Dividend News Dividend Calendar. ETFs. ETF Center ...Stock Price Statistics The stock price has decreased by -30.00% in the last 52 weeks. The beta is 0.64, so IDXG's price volatility has been lower than the market average. gehc stock price todaymonthly aircraft renters insurance Part of Company’s Site Consolidation and Cost Savings Measures . Parsippany, NJ, March 17, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (OTC: IDXG) announced today that it has entered into a definitive agreement to sell its New Haven CT CLIA certified, CAP accredited laboratory to DiamiR Biosciences, Corp. …١١ ذو الحجة ١٤٤٠ هـ ... Sekarang sudah ada 2 Indeks baru nih di BEI! IDX Value30 (IDXV30) & IDX Growth30 (IDXG30). IDX Value30 (IDXV30) adalah 30 saham yang ... ispr stock Interpace Biosciences Inc. 1.05. Delayed Data. As of Nov 21. -0.09 / -7.89%. Today’s Change. 0.51. Today ||| 52-Week Range. 3.54.Dr D IDXG stock SEC Form 4 insiders trading. Dr has made over 1 trades of the Interpace Biosciences Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he bought 10,855 units of IDXG stock worth $94,221 on 21 May 2021.10,855 units of IDXG stock worth $94,221 on 21 May 2021.See historical performance and comparison. View Valuation. Research Interpace Biosciences' (OTCPK:IDXG) stock price, latest news & stock analysis. Find …